CDKN2A and chondrosarcoma: These telomere gene abnormalities are accompanied by IDH1/IDH2 mutations, CDKN2A/2B deletions, and TP53 mutations, suggesting a possible association and synergistic effect between these genes in chondrosarcoma progression [67].